CD4 and neoplasm: Although proper activation of DCs for induction of CTL responses can be achieved by both CD4+-dependent and independent pathways (Schuurhuis et al, 2000), the help of Th epitopes and CD4+ T-lymphocytes has been shown to be crucial in optimising CTL responses and for efficient and long-lasting immunity against tumours (Toes et al, 1999).